REYKJAVIK, Iceland--(BUSINESS WIRE)--EpiEndo Pharmaceuticals (‘EpiEndo’), the clinical-stage biopharmaceutical company developing disease-modifying therapeutics for chronic respiratory disorders, has ...
NORFOLK, Va.--(BUSINESS WIRE)--ReAlta Life Sciences, Inc. (“ReAlta”) a clinical stage, rare disease company addressing life-threatening diseases through harnessing the power of the immune system, ...
LONDON, UK / ACCESSWIRE / December 12, 2022 / Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF) 'Poolbeg' or the 'Company'), a leading infectious disease focused biopharmaceutical company, announces that, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback